C14ORF109 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.335000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.109800E-01
Normal-vs-Stage2
3.373800E-01
Normal-vs-Stage3
1.967840E-01
Normal-vs-Stage4
9.552400E-01
Stage1-vs-Stage2
2.742400E-01
Stage1-vs-Stage3
1.585770E-01
Stage1-vs-Stage4
8.489000E-01
Stage2-vs-Stage3
1.354360E-01
Stage2-vs-Stage4
2.286800E-01
Stage3-vs-Stage4
1.343560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.390000E-01
Normal-vs-AfricanAmerican
5.018600E-01
Normal-vs-Asian
4.705200E-01
Caucasian-vs-AfricanAmerican
9.567200E-01
Caucasian-vs-Asian
7.365600E-01
AfricanAmerican-vs-Asian
8.123400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.047400E-01
Normal-vs-Female
4.819600E-01
Male-vs-Female
9.313400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.396600E-01
Normal-vs-Age(41-60Yrs)
6.418200E-01
Normal-vs-Age(61-80Yrs)
3.231800E-01
Normal-vs-Age(81-100Yrs)
5.236400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.281200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.273640E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.780200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.014200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.488400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.672600E-01
Normal-vs-Daily Drinker
2.135400E-01
Normal-vs-Weekly Drinker
9.771600E-02
Normal-vs-Occasional Drinker
6.846200E-01
Normal-vs-Social Drinker
7.762000E-01
Non Drinker-vs-Daily Drinker
8.375200E-01
Non Drinker-vs-Weekly Drinker
4.412800E-01
Non Drinker-vs-Occasional Drinker
3.594200E-01
Non Drinker-vs-Social Drinker
2.958400E-01
Daily Drinker-vs-Weekly Drinker
4.745200E-01
Daily Drinker-vs-Occasional Drinker
2.470400E-01
Daily Drinker-vs-Social Drinker
1.977600E-01
Weekly Drinker-vs-Occasional Drinker
1.217230E-01
Weekly Drinker-vs-Social Drinker
1.036810E-01
Occasional Drinker-vs-Social Drinker
8.608600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.343400E-01
Normal-vs-Grade 2
1.068800E-01
Normal-vs-Grade 3
1.803430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.002600E-01
Grade 1-vs-Grade 3
2.949600E-01
Grade 1-vs-Grade 4
2.343400E-01
Grade 2-vs-Grade 3
8.748800E-01
Grade 2-vs-Grade 4
1.068800E-01
Grade 3-vs-Grade 4
1.803430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.683600E-01
Normal-vs-NonDiabetic
3.680400E-01
Diabetic-vs-NonDiabetic
6.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.432000E-02
Normal-vs-NoPancreatitis
4.456000E-01
Pancreatitis-vs-NoPancreatitis
4.864100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.649400E-01
Normal-vs-N1
3.863400E-01
N0-vs-N1
9.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.229600E-01
Normal-vs-TP53-NonMutant
3.848200E-01
TP53-Mutant-vs-TP53-NonMutant
6.395800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
